Media Summary: Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for MUSC Hollings Cancer Center radiation oncologist Dr. David Marshall reviews the treatment options for PCRI's Executive Director, Mark Scholz, MD, compares different treatments for men with Teal stage (
Intermediate Risk Do You Need - Detailed Analysis & Overview
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for MUSC Hollings Cancer Center radiation oncologist Dr. David Marshall reviews the treatment options for PCRI's Executive Director, Mark Scholz, MD, compares different treatments for men with Teal stage ( David T. Marshall, M.D., is a board-certified radiation oncologist, specializing in genitourinary and gastrointestinal cancers at ... Mark Scholz, MD, a medical oncologist specializing in prostate cancer, answers YouTuber's questions about hormone therapy ... Dr Mack Roach III speaks to ecancer about early results of a phase III randomised controlled trial. The trial investigated androgen ...
The panelists, Adam Brufsky, MD; Christy Russell, MD; and Hope Rugo, MD, highlight new data regarding the treatment of ... Dr. Mark Emberton presented “Focal Therapy for Men with Dr. Larry Goldenberg, Professor & Head, Department of Urologic Sciences, and Director of Development, the Vancouver Prostate ... James A. Eastham, MD, FACS, considers how to select candidates for active surveillance in the
